CAS 37538-67-3

Pyrido[3,2-d]pyrimidin-4(3H)-one

Description:

Pyrido[3,2-d]pyrimidin-4(3H)-one is a heterocyclic organic compound characterized by a fused ring system that incorporates both pyridine and pyrimidine structures. This compound features a pyridine ring fused to a pyrimidinone, which contributes to its unique chemical properties. It typically exhibits a solid-state at room temperature and is soluble in polar organic solvents. The presence of nitrogen atoms in its structure can influence its reactivity, making it a potential candidate for various chemical reactions, including nucleophilic substitutions and coordination with metal ions. Pyrido[3,2-d]pyrimidin-4(3H)-one may also display biological activity, which has led to interest in its potential applications in pharmaceuticals, particularly as a scaffold for drug development. Its molecular structure allows for various functionalizations, which can enhance its biological efficacy or alter its physicochemical properties. Overall, this compound is of interest in both synthetic organic chemistry and medicinal chemistry due to its structural complexity and potential utility.

Pyrido[3,2-d]pyrimidin-4(1H)-one (9CI)

CAS: 37538-67-3

Formula: C₇H₅N₃O

Purity: 98%

Color and Shape: Solid

Molecular weight: 147.1341

Ref: IN-DA00CAZ0

Pyrido[3,2-d]pyrimidin-4(3H)-one

CAS: 37538-67-3

Pyrido[3,2-d]pyrimidin-4(3H)-one

Purity: 97%

Molecular weight: 147.13g/mol

Ref: 54-OR923956

Pyrido[3,2-d]pyrimidin-4(3H)-one

CAS: 37538-67-3

Formula: C₇H₅N₃O

Purity: 98%

Color and Shape: Solid

Molecular weight: 147.137

Ref: 10-F232787

Pyrido[3,2-d]pyrimidin-4(3H)-one

CAS: 37538-67-3

Pyrido[3,2-d]pyrimidin-4(3H)-one is a molecule that belongs to the class of antimalarial drugs. It inhibits plasmodium falciparum by inhibiting the biosynthesis of purine nucleotides. Pyrido[3,2-d]pyrimidin-4(3H)-one is chemically reactive and apolar. It was isolated from a chemically synthesized compound as an isomer mixture and has been shown to have high activity against erythrocytic stages of plasmodium falciparum in vitro. Pyrido[3,2-d]pyrimidin-4(3H)-one also has a clinical drug application in incrementing the response to other antimalarial drugs.

Formula: C₇H₅N₃O

Purity: Min. 95%

Molecular weight: 147.13 g/mol

Ref: 3D-MBA53867